Comera Life Sciences Financials
We suggest to use Comera Life Sciences fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Comera Life Sciences is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate data for thirty-one available fundamental indicators for Comera Life Sciences, which can be compared to its peers.
Comera |
Understanding current and past Comera Life Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Comera Life's financial statements are interrelated, with each one affecting the others. For example, an increase in Comera Life's assets may result in an increase in income on the income statement.
Please note, the presentation of Comera Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Comera Life's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Comera Life's management manipulating its earnings.
Comera Life Stock Summary
Comera Life competes with SAB Biotherapeutics, Processa Pharmaceuticals, Third Harmonic, Indaptus Therapeutics, and Rezolute. Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts. Comera Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US20037C1080 |
| Business Address | 12 Gill Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | comeralifesciences.com |
| Phone | 617 871 2101 |
| Currency | USD - US Dollar |
Comera Life Key Financial Ratios
Comera Life's financial ratios allow both analysts and investors to convert raw data from Comera Life's financial statements into concise, actionable information that can be used to evaluate the performance of Comera Life over time and compare it to other companies across industries.| Return On Equity | -16.29 | |||
| Return On Asset | -1.19 | |||
| Number Of Employees | 12 | |||
| Beta | 1.16 | |||
| Z Score | -20.09 |
Comera Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Comera Life's current stock value. Our valuation model uses many indicators to compare Comera Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Comera Life competition to find correlations between indicators driving Comera Life's intrinsic value. More Info.Comera Life Sciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Comera Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Comera Life's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Comera Pink Sheet
If you are still planning to invest in Comera Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Comera Life's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |